Pharmaron Beijing Co Ltd is a CN-based company operating in Life Sciences Tools & Services industry. The company is headquartered in Beijing, Beijing and currently employs 21,370 full-time employees. The company went IPO on 2019-01-28. Pharmaron Beijing Co Ltd is a China-based company mainly engaged in pharmaceutical research and development. The firm operates through five segments. The Laboratory Services segment includes laboratory chemistry and bioscience services, covering small molecule drugs, oligonucleotides, peptides, antibodies, antibody-drug conjugates, and cell and gene therapy products. The Chemical and Formulation Process Development and Manufacturing Services segment includes active pharmaceutical ingredient process development and manufacturing, as well as preformulation and formulation development. The Clinical Research Services segment includes international and domestic clinical research services. The Large Molecule and Cell and Gene Therapy Services segment includes large molecule drug discovery, development, and manufacturing services, as well as cell and gene therapy laboratory and gene therapy drug development and manufacturing services. The firm also operates through the others segment.
03759.HK stock price ended at $22.96 on 木曜日, after rising 1.32%
On the latest trading day Jan 08, 2026, the stock price of 03759.HK rose by 1.32%, climbing from $22.66 to $22.96. Throughout the session, the stock experienced a volatility of 3.20%, with prices fluctuating between a daily low of $22.48 and a high of $23.20. Alongside this price increase, trading volume also rose by 1.4M shares, reflecting strong market interest that may signal continued bullish momentum in the near term. In total, 5.6M shares were traded, amounting to a market value of approximately $6.9B.